A detailed history of Sessa Capital Im, L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Sessa Capital Im, L.P. holds 1,806,988 shares of ABT stock, worth $246 Million. This represents 9.93% of its overall portfolio holdings.

Number of Shares
1,806,988
Previous 4,006,723 54.9%
Holding current value
$246 Million
Previous $453 Million 47.11%
% of portfolio
9.93%
Previous 17.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

SELL
$111.1 - $140.22 $244 Million - $308 Million
-2,199,735 Reduced 54.9%
1,806,988 $240 Million
Q4 2024

Feb 14, 2025

BUY
$111.93 - $119.39 $28.8 Million - $30.7 Million
257,221 Added 6.86%
4,006,723 $453 Million
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $120 Million - $142 Million
1,200,409 Added 47.09%
3,749,502 $427 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $257 Million - $287 Million
2,549,093 New
2,549,093 $265 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $238B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sessa Capital Im, L.P. Portfolio

Follow Sessa Capital Im, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sessa Capital Im, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Sessa Capital Im, L.P. with notifications on news.